Feds' new campaign against youth vaping 'epidemic' targets middle and high schoolers

Feds' new campaign against youth vaping 'epidemic' targets middle and high schoolers

CLOSE Teen vaping is reaching epidemic levels and FDA is considering regulation to curb it. One proposal would be banning flavoring of e-cigarette liquids. USA TODAY The Food and Drug Administration’s new “The Real Cost” anti-vaping campaign starts Tuesday.(Photo: Food and Drug Administration) The Food and Drug Administration is launching a first-of-its-kind public service campaign against […]

Cytori Therapeutics (CYTX) Granted FDA Orphan Drug Designation for ATI-1123 Chemotherapy Drug Product Candidate

Cytori Therapeutics (CYTX) Granted FDA Orphan Drug Designation for ATI-1123 Chemotherapy Drug Product Candidate

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here. Cytori Therapeutics (NASDAQ: CYTX) (“Cytori” or the “Company”) today announced that it received FDA orphan drug designation for its ATI-1123 chemotherapy drug product candidate, an albumin-stabilized pegylated liposomal docetaxel, for the treatment of small […]

FDA Warns Some Pet Owners Are Abusing Opioids Prescribed to Their Pet

FDA Warns Some Pet Owners Are Abusing Opioids Prescribed to Their Pet

Opioid abuse is no longer a problem that just doctors and pharmacists have to be proactive about, it is now spilling over into veterinary medicine. In August, the Food and Drug Administration put out a warning about pet owners abusing drugs prescribed to their animals. There is also growing evidence they are intentionally hurting pets […]

Cayman company's ADHD drug approved by FDA

Cayman company's ADHD drug approved by FDA

​A pharmaceutical company based in the Cayman Islands ​says it has developed the only stimulant medication to treat symptoms of Attention Deficit Hyperactivity Disorder that is dosed in the evening for effectiveness in early morning and throughout the day. Ironshore Pharmaceuticals said in a press release the U.S. Food and Drug Administration approved the New […]

FDA Approves 2nd Migraine Prevention Drug

FDA Approves 2nd Migraine Prevention Drug

Tips for Living With Migraine By Deborah Brauser Sept. 17, 2018 — The FDA has approved Ajovy, a new drug for migraine prevention in adults, the manufacturer, Teva Pharmaceuticals, has announced. The injectable drug, known […]

FDA approves Teva's migraine prevention drug

FDA approves Teva's migraine prevention drug

The FDA approved Ajovy subcutaneous injections at doses of either 675 mg quarterly or 225 mg monthly for the prevention of migraine in adults, Teva announced. Ajovy (fremanezumab-vfrm, Teva) blocks the activity of calcitonin gene-related peptide (CGRP), a molecule involved in migraine attacks, the FDA said. The benefits of fremanezumab-vfrm have been reported in several […]

FDA approves Teva's migraine drug, decision due on Lilly's rival

FDA approves Teva's migraine drug, decision due on Lilly's rival

The FDA has finally approved Teva’s potential blockbuster migraine drug Ajovy after months of delays due to concerns about the manufacturing plant operated by the company’s partner, Celltrion. Teva had originally expected FDA approval in June for Ajovy (fremanezumab), but had to wait until the regulator was satisfied with the factory operations in South Korea. […]